Reynolds Crossing Office (formerly Patterson Office)
6946 Forest Avenue Suite 200
Richmond, Virginia 23230
Colonial Heights Office
280 Charles H. Dimmock Parkway, Suite 4
Colonial Heights, VA 23834
Midlothian Office
The Winchester Building 10800 Midlothian Turnpike, Suite 309
Richmond, VA 23235
Mohs Surgery Center
The Winchester Building 10800 Midlothian Turnpike, Suite 310
Richmond, VA 23235
Nuckols Road Office
201 Concourse Boulevard, Suite 110
Glen Allen, VA 23059
Hanover Office
7498 Right Flank Road
Mechanicsville, Virginia 23116
Dermatology Associates of Virginia is open and seeing patients at each of our locations.
We are seeing all patient visits at this time. Certain visits, such as acne concerns, can be seen remotely with one of our providers. If you are interested in scheduling a telehealth visit, please contact our scheduling department at (804) 549-4040.
Throughout the pandemic we have kept the safety and health of our patients, providers, and staff first. As of 2021, 100% of DAV Providers are now vaccinated.
At Dermatology Associates of Virginia, we are committed to providing excellent care while prioritizing the health of our patients and staff. As the COVID-19 pandemic continues to impact our communities as well as the rest of the world, our team has been taking the necessary precautions to ensure our offices are properly sanitized and safe as possible for everyone.
We ask that any patient who is experiencing fevers, cough, or other symptoms of an infection, to please reschedule upcoming appointments until a time when you have fully recovered.
Below, you can read more about what to expect for your appointment as well as the steps we’re taking to ensure our patients and associates remain safe and in good health during this time.
For details of CDC recommendations regarding Coronavirus precautions, please visit: https://www.cdc.gov/coronavirus/2019-ncov/index.html
To visit the Virginia Department of Health recommendations regarding Coronavirus precautions, please visit: http://www.vdh.virginia.gov/surveillance-and-investigation/novel-coronavirus/